What caused the volume spike in 9906.HK stock today?

The spike reflects concentrated intraday orders: **64,000** shares traded versus average **1,193**. Low normal liquidity makes block trades or fund flows magnify volume. Confirm with order‑book data and follow‑through volume to judge news versus speculative activity.

Is 9906.HK stock a buy after the volume spike?

Meyka AI grades 9906.HK as **B (HOLD)**. Short‑term traders may act on confirmed follow‑through above **HK$1.69**. Longer term, valuation and earnings outlook must improve before a buy recommendation.

What are reasonable price targets for 9906.HK stock?

Near‑term technical targets: resistance **HK$1.69** and **HK$1.82**. Scenario targets: bull **HK$2.00**, base **HK$1.64**, bear **HK$1.20**. Use stops and size positions to liquidity.

How does Meyka AI forecast compare to current price for 9906.HK stock?

Meyka AI's yearly forecast is **HK$1.19**, compared with the intraday price **HK$1.64**, implying an estimated downside **-27.56%**. Forecasts are model‑based projections and not guarantees.

HK Stocks

Volume spike lifts 9906.HK Honliv Healthcare (HKSE) to HK$1.64 intraday on 18 Feb 2026: track liquidity and next price signals

ByDanny Kontos February 18, 2026February 18, 2026

A sudden intraday volume spike — 64,000 shares versus an average of 1,193 — lifted 9906.HK stock to HK$1.64 on 18 Feb 2026 in Hong Kong trading. The move showed a relative volume of 53.65 and kept price within a tight session range of HK$1.64–1.65. Intraday traders should note the contrast between today’s flows and the 50‑day average price HK$1.69 and the 200‑day average HK$1.58. We track whether this liquidity surge reflects information flow, short covering, or block trades that can set the next directional bias for Honliv Healthcare Management Group Company Limited on the HKSE.